General
Preferred name
DITOLYLGUANIDINE
Synonyms
DTG ()
1,3-DI-O-TOLYLGUANIDINE ()
1,3-ditolylguanidine ()
[3H]-di-o-tolylguanidine ()
P&D ID
PD021896
CAS
97-39-2
132116-33-7
75535-12-5
Tags
available
drug candidate
Drug indication
Discovery agent
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ditolylguanidine (1,3-Di-o-tolylguanidine) is an agonist of sigma receptor (¦Ò1/¦Ò2 receptor) with Ki values of 69 and 21 nM for ¦Ò1 and ¦Ò2 receptors, respectively. Ditolylguanidine effectively inhibits the growth of small cell lung cancer cells. Ditolylguanidine can be used for the research of lung cancer[1][2][3][4].
DESCRIPTION
High affinity ligand (σ1 = σ2)
(Tocriscreen Total)
DESCRIPTION
DTG has been found to be a σ-receptor agonist and is useful in studies of its interaction with dopamine drug.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
13
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Drug Repurposing Hub
DrugMAP
DrugMatrix
Ki Database
MedChem Express Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
34
Molecular Weight
239.14
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
2
cLogP
3.76
TPSA
47.91
Fraction CSP3
0.13
Chiral centers
0.0
Largest ring
6.0
QED
0.55
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
GRIN1, GRIN2A, GRIN2B, SIGMAR1
Sigma Receptor
MOA
Sigma Receptor agonist
Pathway
Neuronal Signaling
Source data
